LCM
MAIA icon

Lazari Capital Management’s MAIA Biotechnology MAIA Stock Holding History

Lazari Capital Management’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.3K Buy
+21,750
New +$28.9K 0.01% 183

Other funds holding MAIA

PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
CAG
Centerpoint Advisory Group Overland Park, Kansas $158M AUM 26.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Lazari Capital Management's MAIA Position: Q2 2026 in Review

Lazari Capital Management opened a new position in MAIA Biotechnology (MAIA) in Q2 2026: 21,750 shares worth $31.3K. The stake represents 0.01% of the portfolio and ranks #183 among its holdings.

5 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Lazari Capital Management held 21,750 shares of MAIA Biotechnology worth $31.3K as of Q2 2026.
  • MAIA Biotechnology was a new Lazari Capital Management position in Q2 2026.
  • MAIA Biotechnology made up 0.01% of Lazari Capital Management's portfolio in Q2 2026, its #183 holding.
  • 5 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Lazari Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.